New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2013
11:31 EDTAET, CVLT, IRM, MW, RADHigh option volume stocks: MW RAD CVLT AET IRM
News For MW;RAD;CVLT;AET;IRM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 8, 2015
16:01 EDTRADActionable Options for Wednesday, April, 8
Subscribe for More Information
09:55 EDTRADRite Aid guidance looks conservative, says JPMorgan
Subscribe for More Information
09:35 EDTRADActive equity options trading on open
Subscribe for More Information
07:13 EDTRADRite Aid up 3.6% after reporting Q4 results
Subscribe for More Information
07:08 EDTRADRite Aid reports Q4 SSS up 4.5%
Same store sales for the quarter increased 4.5% over the prior year, consisting of a 5.7% increase in pharmacy sales and a 2.0% increase in front-end sales. Pharmacy sales included a negative impact of approximately 128 basis points from new generic introductions. The number of prescriptions filled in same stores increased 3.5% over the prior year period. Prescription sales accounted for 68.1% of total drugstore sales, and third party prescription revenue was 97.5% of pharmacy sales.
07:05 EDTRADRite Aid sees FY16 EPS 19c-27c, consensus 43c
Subscribe for More Information
07:03 EDTRADRite Aid reports Q4 EPS ex-items 12c, consensus 7c
Reports Q4 revenue $6.85B, consensus $6.8B. Reports Q4 net income of $1.835B, or $1.79 per diluted share. Current year results for both Q4 and the full year were favorably impacted by a reduction of the deferred tax asset valuation allowance and a full year provision of income tax expense at a statutory tax rate, the net effect of which resulted in an income tax benefit of $1.716B, or $1.67 per diluted share and $1.682B, or $1.65 per diluted share in the fourth quarter and full year, respectively.
April 7, 2015
15:43 EDTRADRite Aid trades at multi-year highs ahead of earnings, levels to watch
Subscribe for More Information
15:30 EDTRADNotable companies reporting before tomorrow's open
Subscribe for More Information
10:23 EDTAETMedicare Advantage 2016 rates set above expectations
The U.S. yesterday announced higher than expected 2016 Medicare Advantage reimbursement rates. The news is seen as benefiting managed care companies with large exposure to the Medicare Advantage program. WHAT'S NEW: The Centers for Medicare and Medicaid Services, or CMS, yesterday afternoon announced that Medicare Advantage reimbursement rates would rise 1.25% in 2016 from 2015 levels. In February, CMS proposed a 0.95% reduction in Medicare Advantage reimbursement rates for 2016. This year, reimbursement rates have fallen 4%. WHAT'S NOTABLE: Humana (HUM) said this morning in a regulatory filing that based on its review of the Final Rate Notice, the company expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation, the company explained. ANALYST REACTION: In a note to investors earlier today, Deutsche Bank analyst Scott Fidel wrote that this is the first time in seven years that CMS has implemented an increase in Medicare Advantage rates. However, noting that CMS said it had raised its estimates for Medicare costs, Fidel added that this forecast tempered the positive outlook created by the reimbursement increase. The analyst kept Buy ratings on the following stocks in the sector: Aetna (AET), Anthem (ANTM), Cigna (CI), Magellan Health (MGLN), and UnitedHealth (UNH). Stifel analysts said that the results were modestly better than expected, except for the agency's decision not to make a Star rating adjustment for plans with certain higher acuity populations. The firm thinks that more diversified managed care companies with Medicare Advantage products could be boosted by CMS' decision, identifying Aetna, Humana, and UnitedHealth as being among the companies in that category. PRICE ACTION: In early trading, Aetna was little changed at $107.40, Anthem was flat near $155 per share, Cigna slipped 0.4% to $131.34, Magellan was flat at $71, UnitedHealth added 0.5% to $118.31 and Humana gained fractionally to $178.54.
08:37 EDTRADRite Aid volatility increases into Q4 and outlook
Subscribe for More Information
08:35 EDTRADReed's announces Sonoma Sparklers available at Rite Aid locations
Reed's (REED) announced that Reed's Sonoma Sparklers is now available exclusively in Rite Aid (RAD) stores nationwide. All of the nearly 4,600 Rite Aid stores across the U.S. will feature 16oz bottles of delicious, all-natural Sonoma Sparklers in three flavors: Sparkling Organic Raspberry, Sparkling Organic Lemonade and Sparkling Organic Peach.
08:20 EDTAETCowen expects managed care stocks to outperform following CMS release
Cowen expects managed care stocks to outperform today following the CMS release outlining better than expected Medicare Advantage rates for 2016. The firm also sees improved FFS growth rates, maintained coding intensity adjustment, and continued HRA payments. Publicly traded companies in the space include Aetna (AET), Cigna (CI), Health Net (HNT), Humana (HUM), and WellCare (WCG).
08:02 EDTRADJPMorgan says Walgreens may be more willing to buy Rite Aid
Subscribe for More Information
07:44 EDTAETSome managed care stocks could be boosted by CMS decision, says Stifel
Subscribe for More Information
07:41 EDTAET2016 MA rates positive for first time in seven years, says Deutsche Bank
Deutsche Bank notes that for the first time since 2009, Medicare Advantage rates will be positive after the Centers for Medicare and Medicaid Services announced yesterday that final 2016 rates will rise by 1.25%, representing a 220 basis points favorable swing from the preliminary proposed cut of 0.95%. Deutsche says the positive surprise is "somewhat tempered" by the more cautious view on Medicare cost trends provided by the CMS actuaries in the final 2016 rate announcement. The firm expects Humana (HUM), Health Net (HNT) and UnitedHealth (UNH), Aetna (AET) and Anthem (ANTM) to experience Medicare Advantage rate increases.
06:56 EDTAETAetna CEO sees 'groundswell' of wage increases in coming months, WSJ reports
Mark Bertolini, the CEO of Aetna, says he believes there will be a "groundswell" of pay increases for the lowest-paid employees at big companies in the next few months, The Wall Street Journal reports. Bertolini commented at a Peterson Institute for International Economics event that he believes "there are a number of CEOs that will come out in the next six months with wage increases that will matter." Reference Link
April 6, 2015
07:57 EDTAETLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte discusses the leverage Anthem likely has in its Pharmacy Benefit Manager (PBM) contract with Express Scripts and how it changes after the Catamaran-Optum Rx deal, the synergy potential for the deal between Catamaran and Optum Rx and the likelihood of Cigna-HS remaining with the newly merged Optum Rx-CTRX on an Analyst/Industry conference call to be held on April 6 at 2 pm.
07:12 EDTRADRite Aid volatility elevated into Q4 and outlook
Subscribe for More Information
06:58 EDTRADRite Aid reinstated with an Overweight at JPMorgan
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use